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Abstract
Background
Typhoid fever, caused by the intracellular pathogen Salmonella (S.) enterica serovar
Typhi, remains a major cause of morbidity and mortality worldwide. Granzymes are serine
proteases promoting cytotoxic lymphocytes mediated eradication of intracellular patho-
gens via the induction of cell death and which can also play a role in inflammation. We
aimed to characterize the expression of extracellular and intracellular granzymes in
patients with typhoid fever and whether the extracellular levels of granzyme correlated
with IFN-γ release.
Methods and principal findings
We analyzed soluble protein levels of extracellular granzyme A and B in healthy volun-
teers and patients with confirmed S. Typhi infection on admission and day of discharge,
and investigated whether this correlated with interferon (IFN)-γ release, a cytokine
significantly expressed in typhoid fever. The intracellular expression of granzyme A, B
and K in subsets of lymphocytic cells was determined using flow cytometry. Patients dem-
onstrated a marked increase of extracellular granzyme A and B in acute phase plasma
and a correlation of both granzymes with IFN-γ release. In patients, lower plasma levels
of granzyme B, but not granzyme A, were found at day of discharge compared to admis-
sion, indicating an association of granzyme B with stage of disease. Peripheral blood
mononuclear cells of typhoid fever patients had a higher percentage of lymphocytic cells
expressing intracellular granzyme A and granzyme B, but not granzyme K, compared to
controls.
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Conclusion
The marked increase observed in extra- and intracellular levels of granzyme expression in
patients with typhoid fever, and the correlation with stage of disease, suggests a role for
granzymes in the host response to this disease.
Author summary
Typhoid fever is an (sub)acute febrile illness that remains an important global burden
with more than 27 million cases worldwide each year and an estimated 217,000 deaths.
During infection by Salmonella (S.) Typhi, the etiologic agent for typhoid fever, a cascade
of antimicrobial functions is triggered and causes release of signaling and cytotoxic pro-
teins for the rapid control of the infection.
Granzymes are proteins promoting cytotoxic lymphocytes mediated eradication of
intracellular pathogens via the induction of cell death and which can also play a role in
inflammation. In the present study we analyzed extracellular levels of different granzymes
in healthy volunteers and patients with confirmed S. Typhi infection at the time of admis-
sion and discharge, as well as their correlation with levels of interferon (IFN)-γ, a cytokine
significantly expressed in typhoid fever. Patients demonstrated a marked increase of extra-
cellular released granzyme A and B in acute phase plasma, which correlated with IFN-γ
levels, while granzyme B levels were associated with disease stage. Intracellular expression
of both granzymes was also increased in patients compared to controls. In conclusion,
granzymes are markedly elevated in human typhoid and correlate with stage of disease,
suggesting their involvement in the host response to the disease.
Introduction
Typhoid fever, caused by the intracellular and human-specific Gram-negative bacterium Sal-
monella (S.) enterica serovar Typhi, remains an important cause of illness and death in many
parts of the world. The global burden of this systemic infection is estimated to be around 26.9
million cases of per year resulting in over 200,000 deaths annually [1–3]. However, the remark-
able mechanisms for cellular persistence of S. Typhi remain ill defined.
Cellular mediated immune responses against S. Typhi infection rely largely on two types of
lymphocytic cells: CD4+ and CD8+ T cells [4]. The presence of both CD4+ helper T cells and S.
Typhi-specific CD8+ T cells has been observed in humans challenged with oral S. Typhi or
immunized with the attenuated oral Ty21a typhoid vaccine [4, 5]. Cytotoxic CD8+ T cells
and natural killer (NK) cells are important effector cells of cell-mediated immunity and are
involved in adaptive and innate immune responses. It is well established that T lymphocytes
and NK cells are important sources of interferon (IFN)-γ, a critical cytokine for systemic con-
trol of Salmonella infection [6]. Interestingly, a human vaccine study showed that the killing of
S. Typhi-infected cells by specific CD8+ T cells is executed through a Fas-independent, but
granule-dependent mechanism, which suggests a role for granzymes in the containment of S.
Typhi [7]. Granzymes are a family of serine proteases found in the cytoplasmic granules of
cytotoxic lymphocytes. To date, five human granzymes (A, B, H, K and M) have been
described of which granzyme A and B have been studied most extensively [8]. The classic role
of granzymes is to promote cytotoxic lymphocytes-mediated eradication of infected, neoplas-
tic, or foreign cells via the induction of cell death. However, it is now accepted that granzymes
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can be expressed in other cell types of immune and non-immune origin, and increasing evi-
dence support that they can also play a role in inflammation [9]. Extracellular granzymes have
been shown to exhibit different functions i.e. propagate inflammation and cytokine processing
but not cell death [10]. Circulating granzymes can be measured in the plasma of patients and
are considered to reflect the involvement of cytotoxic CD8+ T cells and NK cells in diverse dis-
ease states [11]. Elevated levels of granzyme B are a characteristic feature of various chronic
inflammatory diseases and are thought to reflect a state of hyper-inflammation [10, 12]. Fur-
thermore, it has been shown that granzymes are elevated in patients with malaria, endotoxe-
mia, sepsis and tuberculosis [8, 12–14]. However, the expression of intra- and extracellular
granzymes in patients with S. Typhi infection has, to the best of our knowledge, never been
studied.
In the present study, we aimed to characterize the expression of extracellular and intracellu-
lar granzymes in patients with typhoid fever. For this, we analyzed the extracellular levels of
granzyme A and B, as well as the intracellular expression of granzymes A, B and K in lympho-
cyte subsets, in patients with culture-proven typhoid fever compared to controls. We also
investigated whether the extracellular levels of granzyme correlated with IFN-γ release.
Materials and methods
Patients and study design
A total of 143 eligible febrile adult patients were prospectively recruited over a 6-month period
in 2012 after admission to Chittagong Medical College Hospital, a 1,000-bed government hos-
pital located in Chittagong, eastern Bangladesh. From all these febrile patients, blood samples
(24 mL) were obtained within 48 hours after admission to the hospital and at discharge, and
were collected into EDTA or heparin tubes (BD vacutainer), or BactAlert blood culture bottles
(bioMe´rieux). A total of 28 of the 143 febrile patients tested positive for S. Typhi either with
blood-culture and/or S. Typhi PCR in blood, urine or feces as described [15].
From a subset of 8 patients with only blood-culture confirmed typhoid fever additional
consent was required and blood was drawn (30 mL) within 72 hours and collected in CPT Cell
Preparation Tubes with sodium heparin for cell separation (BD Vacutainer).
Thirty-eight healthy Bangladeshi volunteers from among the hospital staff who were
known to have no illness and were not currently receiving any medication were recruited and
served as control population.
Ethics statement
The study protocol was approved by the National Research Ethics Committee (NREC) of Ban-
gladesh (BMRC/NREC/2010-2013/1543) and the Oxford Tropical Research Ethics committee
(OXTREC reference 25–11). Informed written or thumbprint consent was taken from the sub-
ject or caretaker for all cases and controls.
Assays
Plasma samples were stored immediately at −20˚C after obtention. Soluble granzyme A and B
were measured by sandwich ELISA (eBioscience; LD 2 pg/ml) in plasma, in accordance with
the manufacturer’s recommendations. Human tumour necrosis factor (TNF)-α, interleukin
(IL)-1β, IL-6, IL-8, IL-10, IL-12p70, and IFN-γ were measured by cytometric-bead-array mul-
tiplex assay (BD Biosciences; LD 0.5 pg/mL). Aspartate transaminase (AST), alanine transami-
nase (ALT) and renal function were measured in plasma with spectrophotometry (Roche
Diagnostics) as for previous study [16].
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Flow cytometry
Peripheral blood mononuclear cells (PBMCs) were isolated from blood collected in CPT Cell
Preparation Tubes and handled according to manufacturer’s instructions (BD Vacutainer).
After isolation, PBMCs were counted using count chamber (Loptik labor) and cells were sus-
pended in RPMI 1640 (Gibco) with 20% Fetal Bovine Serum (FBS; Lonza). Another equal vol-
ume of RPMI with 20% FBS and dimethyl sulfoxide (Gibco) was gently added to the cryovial
drop by drop. To ensure stepwise temperature decrease, cryovials containing PBMCs were put
in an alcohol-free container using a temperature exchange system (CoolCell, Biocision) to
achieve temperature lowering at ~1˚C/min rate and placed in a −80˚C refrigerator before ship-
ment. Prior to analysis stored cells were carefully thawed, washed and stained with monoclonal
antibodies against CD3 (AF700), CD4 (PerCP-Cy5.5), CD56 (APC) (all from BD Pharmingen)
and CD8 (PE-Cy7; Biolegend), at 4˚C for 25 min in the dark. For the intracellular staining,
cells were fixed for 20 min in Cytofix/Cytoperm (BD Bioscience) at 4˚C in the dark before
washing. Subsequently, the cells were suspended in a buffer containing the antibodies against
granzyme A (PE; BD Pharmingen), granzyme B (PE-CF594; BD Horizon) and granzyme K
(FITC; Santa Cruz Biotechnology) before analyzing with a FACSCanto (BD Bioscience).
FlowJo software (Tree Star Inc.) was used for analysis. Lymphocytes were gated in the forward
scatter versus side scatter dot plot. Cells were selected as CD3+ or CD56+, or as CD3+CD4+
(CD4+ T cells), CD3+CD8+ (CD8+ T cells), CD3+CD56+ (CD56+ T cells) and CD3−CD56+
(NK cells), and expression of granzymes was analyzed in these populations as described previ-
ously [14]. The results are expressed as percentage of cells of the specific lymphocyte popula-
tion expressing the corresponding granzyme and as the median fluorescence intensity (MFI).
Alternatively, to analyze the lymphocyte source of each granzyme, cells were selected as posi-
tive for each granzyme and the percentage of the above-mentioned lymphocyte subpopula-
tions were analyzed within the granzyme-positive lymphocytes.
Statistical analysis
Values are expressed as median and interquartile ranges (IQR) unless indicated otherwise. Dif-
ferences between groups were analyzed by Mann-Whitney U test. For correlations Spearman
Rho is reported. These analyses were performed using GraphPad Prism version 6.0 for Mac
(GraphPad Software) and SPSS version 15.0 (Chicago, Ill, USA). A P<0.05 was considered to
represent a statistically significant difference.
Results
Pro-inflammatory cytokine profile in patients with PCR or culture-proven
typhoid fever
We included 28 patients with confirmed typhoid fever: 11 (39%) of these confirmed cases
were diagnosed by isolation of S. Typhi from blood, and 17 (61%) by positive S. Typhi PCR
in blood (15), urine (2) and/or feces (1) [15]. A summary of baseline clinical features and lab-
oratory results of patients and controls are shown in Table 1. While the total white blood cell
count (WBC) did not differ between patients and controls, there was a significant shift
towards a higher neutrophil and lower lymphocyte count in typhoid fever patients, which is
a characteristic clinical feature for this disease [17]. Consistent with the literature on typhoid
fever [2], levels of IL-6, IL-8, IL12p70 and IFN-γ were significantly increased in patients
compared to controls. However, IFN-γ was the only marker that was significantly increased
when comparing blood-culture negative/PCR positive patients with blood-culture positive
patients (median 2.0 IQR [0.5–156] versus 598 [292–773], P<0.001), suggesting a role for
Granzymes in typhoid fever
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IFN-γ during active bacterial replication of S. Typhi in the blood stream. IL-10 tended to be
elevated in patients but the difference with controls did not reach statistical significance,
partly due to a large inter-individual variation. IL-1β was undetectable and TNF-α was low
in both patients and controls.
Extracellular granzyme A and B levels are highly elevated in patients
with typhoid fever
To first establish the presence of circulating granzymes during clinical typhoid fever we mea-
sured granzyme A and B in the plasma of 28 patients with S. Typhi infection and 38 healthy
controls. Both granzyme A and B were elevated in the plasma of patients with typhoid fever
compared to healthy controls (median 16 IQR [8.8–33] versus 5.7 [3.7–7.1] pg/ml, P<0.001,
Table 1. Demographic, clinical and laboratory features of typhoid fever patients compared to
controls.
Healthy controls
(n = 38)
Patients
(n = 28)
Characteristic
Age (years) 34 (19–55) 28 (20–45)
Sex (male) 19 (50) 16 (57)
Fever duration before admission (days) 0 (0–1) 7 (1–15)***
Duration of admission (days) 0 (0–0) 5 (0–12)***
Death in hospital 0 (0–0) 1 (3.7)
Temperature (Celsius) 36.1 (33.8–37.4) 38.8 (38–40.1)***
Systolic BP (mmHg) 120 (106–169) 116 (85–159)*
Pulse (beats/min) 73 (40–120) 104 (70–150)***
BUN (mg/dL) 6–20a 12.5 (9.3–76)
Serum creatinine (mg/dL) 0.1–0.5a 0.9 (0.6–2.2)
AST (U/L) <40a 40 (13–1430)
ALT (U/L) <45a 49 (15–1199)
Hb (mmol/L) 13.3 (8.4–15.5) 12.1 (3.5–14.5)**
WBC count1 (x109 cells/L) 7.5 (4.5–10) 9 (1.5–29)
Neutrophil (%) 57 (43–76) 77 (3–92)***
Monocyte (%) 3 (2–9.3) 2 (0–7)
Lymphocyte (%) 36 (20–50) 19 (1–36)***
Cytokines (pg/ml)
TNF-α 3.8 (2.4–6.4) 3.8 (3.2–9.4)
IL-8 5.5 (3.3–10) 18.2 (5.1–96)***
IL-6 1.1 (0.5–3.4) 14.5 (2.0–255)***
IL-1β ND ND
IL-10 ND 0.5 (0.5–12.2)
IL-12 0.5 (0.5–2.0) 1.2 (0.5–2.5)*
IFN-γ 0.5 (0.5–4.5) 122.4 (0.5–1619)***
Proportions are expressed as number (%) and continuous variables as median (range). P values are
determined via Mann-Whitney U tests comparing typhoid fever patients to healthy controls.
* P<0.05,
** P<0.01,
*** P<0.001,
a Normal range, not measured in the control group. WBC: white blood cell count. ND: non detectable.
https://doi.org/10.1371/journal.pntd.0005823.t001
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and median 23.3 IQR [5.5–51.3] versus 3.2, [2.4–7.8] pg/ml, P<0.001 respectively; Fig 1A–
1B). In patients, a moderate correlation was seen between granzyme A and B levels (Spear-
man Rho r = 0.60; P<0.001, Fig 1C). Granzyme A levels (P<0.01), but not granzyme B levels
(P = 0.16) were significantly elevated in culture-positive patients compared to culture nega-
tive/PCR-positive patients, which suggests that bacteria circulating in the bloodstream are
inducers of extracellular granzyme A release. We next determined the correlation between
extracellular granzymes and IFN-γ levels, since IFN-γ showed to be an important acute
phase cytokine in this cohort. Positive correlations were observed between IFN-γ and gran-
zyme A (Spearman´s Rho r = 0.80, P<0.001; Fig 1D), and granzyme B (Spearman Rho
r = 0.52, P<0.001; Fig 1E).
Plasma levels of granzyme B, but not granzyme A levels return to normal
on day of discharge
In order to determine if granzyme levels correlated with stage of disease we obtained plasma
samples of patients at discharge and compared them to admission samples. Plasma granzyme
B (median 7.1, IQR [3–11] pg/ml, P<0.05), but not granzyme A levels (median 13.4, IQR [4.5–
16.4] pg/ml, P = 0.26) were decreased at follow-up when patients were clinically improved (Fig
2A–2B). Plasma levels of granzyme B (P = 0.18), but not granzyme A (P<0.01) levels returned
to normal during convalescence comparing samples of healthy controls to patient discharge
samples.
Fig 1. Extracellular levels of granzyme A and B in patients with typhoid fever and healthy controls, and correlation with IFN- γ
levels. Plasma levels of granzyme A (A) and B (B) measured in healthy controls (n = 38) compared to admission samples of hospitalized
typhoid fever patients (n = 28). Medians are shown. Significance determined via Mann-Whitney U tests. ***P<0.001. Granzyme A is
correlated to granzyme B (C). Levels of granzyme A (D) and granzyme B (E) are correlated to interferon (IFN)-γ in patients. Correlation
coefficient reported is for Spearman’s Rho. Gzm: granzyme.
https://doi.org/10.1371/journal.pntd.0005823.g001
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Lymphocytes of typhoid fever patients have a higher expression of
intracellular granzymes than controls
To identify the lymphocytes subsets and the cells expressing intracellular granzymes A, B and
K, flow cytometry was performed in cells from 36 control individuals and from 8 culture-posi-
tive typhoid fever patients. As in the total groups of controls and patients, in these subgroups
both percentage of cells (median 34.5 IQR [31.5–39.3] and 17.5 [15.0–21.0] respectively for
controls and patients; P<0.0001) and cell numbers (median 28.3 IQR [23.4–30.4] and 11.6
[8.1–15.5] cells x 108/L respectively; P<0.0001) were lower in typhoid fever patients. A signifi-
cant decrease in cell numbers of CD8+T, CD4+T, CD56+T and NK cells was found in patients
compared to controls (Table 2). However, only CD4+ T cells presented a lower percentage in
patients. Interestingly, the percentage of NK cells remained unchanged, and CD8+T as well as
CD56+T cells, a subset of innate lymphocytes that possess the characteristics of both NK and T
cells [18], showed higher percentages in the typhoid fever group (Table 2). In line with the
measured extracellular granzyme levels, lymphocytes of typhoid fever patients had a higher
percentage of cells expressing intracellular granzyme A and granzyme B than controls,
although the increase in cell numbers was not significant (Table 2). We also measured the cells
expressing granzyme K, which is thought to stimulate monocytic cells to secrete pro-inflam-
matory mediators like granzyme A [11], and this was increased in typhoid fever patients albeit
not statistically significantly (Table 2). On day of discharge, percentage of total lymphocytes
expressing granzymes remained comparable to day of admission and significantly different
from controls (Table 2). In typhoid fever patients, the number of lymphocytes producing both
granzyme A and B simultaneously was almost doubled compared to controls (25% vs 49%,
P<0.001).
We then analyzed which lymphocyte subsets were expressing each granzyme (that is, the
cellular source). For this, we identified by flow cytometry the cells positive for each granzyme
within the lymphocytes gate, and determined the percentage of cells belonging to each lym-
phocyte subset in each group of granzyme+ cells. As expected [14], we found that CD3+ cells
were the main producers of the three granzymes, with a significant increase in the percentage
of granzyme A and B expressed by CD3+ cells in patients compared to controls (median values
Fig 2. Extracellular levels of granzyme A and B on admission and during discharge in patients. Typhoid fever patients (n = 15) who
were discharged from hospital had lower levels of granzymes at follow-up when patients were clinically improved (granzyme A; A), although
this did only reach statistical significance for granzyme B (B). Medians are shown. Significance determined via Mann-Whitney U tests.
*P<0.05. Gzm: granzyme.
https://doi.org/10.1371/journal.pntd.0005823.g002
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of total cells positive for each granzyme that were CD3+, controls vs patients: 66% vs 87% for
granzyme A, 53% vs 78% for granzyme B, and 91% vs 80% for granzyme K).
Typhoid fever patients have higher percentages of all subsets of cells
expressing granzyme A compared to controls
Next, we determined the percentage of cells that expressed granzymes per lymphocyte subset
(Fig 3A–3D). For this, we identified by flow cytometry each lymphocyte subset within the lym-
phocytes gate, and determined the percentage of granzyme+ cells in each subset. We found
that the percentage of CD8+ T cells, CD4+ T cells, CD56+ T cells, and NK cells positive for
granzyme A was significantly higher in patients compared to controls. The percentage of
CD8+ T cells and CD4+ T cells positive for granzyme B was also significantly higher in patients
than controls. This was not the case for CD56+ T cells or NK cells. Percentages of subset of
lymphocytes expressing granzyme K did not differ between both groups of individuals.
The median fluorescence intensity (MFI) of the three different granzymes (i.e., the amount
of each granzyme expressed by granzyme+ cells) was also determined in each subset of
Table 2. Proportion and cell counts of lymphocyte populations and granzymes in patients with typhoid fever and controls.
Controls Typhoid fever Discharge
Lymphocyte subsets
CD8+ T cells
Cells x 108/L 5.8 [4.5–7.6] 2.9 [2.0–4.2] N/A
% 20.7 [19.3–26.4] 26.8 [22.2–31.6]** 22.9 [20.2–24.8]
CD4+ T cells
Cells x 108/L 8.5 [6.8–11.5] 2.7 [1.2–3.2]*** N/A
% 33.5 [25.8–38.0] 18.0 [14.4–24.4]** 18.4 [13.0–24.4]
CD56+ T cells
Cells x 108/L 0.9 [0.6–1.3] 0.4 [0.1–0.9] N/A
% 3.3 [2.6–4.8] 8.5 [6.3–10.9]* 6.1 [5.4–6.9]
NK cells
Cells x 108/L 3.1 [2.7–3.8] 0.7 [0.4–1.0]** N/A
% 12.6 [8.8–16.4] 12.7 [8.6–17.2] 6.7 [6.3–7.1]
Granzyme A+ cells
Cells x 108/L 26.1 [22.3–33.7] 36.9 [26.8–43.9] N/A
% 35.1 [29.6–41.4] 59.8 [53.6–62.2]*** 60.6 [48.4–69.8]*
Granzyme B+ cells
Cells x 108/L 25.5 [22.6–37.0] 36.6 [29.3–54.5] N/A
% 35.5 [29.3–41.4] 63 [57.2–71.6]*** 70.8 [62.0–77.1]**
Granzyme K+ cells
Cells x 108/L 13.6 [10.9–15.9] 17.7 [10.9–19.8] N/A
% 16.7 [14.6–21.9] 27.8 [18.2–31.8] 37.5 [31.4–43.7]**
Percentage values are percentages of total lymphocytes. Both cells counts and percentages are presented as median [IQR]. Analysis show control versus
typhoid fever patients comparison by non-parametric test for two independent variables, Mann-Whitney U test.
*P<0.05,
**P<0.01,
***P<0.001 vs controls.
For all cells except CD56+: n = 36 for controls, 8 for typhoid admission, 4 for typhoid discharge.
For CD56+ cells: n = 25 for controls, 4 for typhoid admission, 2 for typhoid discharge.
N/A: WBC was not available on day of discharge, therefore total number of cells could not be measured.
https://doi.org/10.1371/journal.pntd.0005823.t002
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lymphocytes (Fig 3E–3H). The MFI of cells expressing granzyme A was significantly increased
in CD8+ T, CD4+ T, CD56+ T and NK cells, whilst the MFI of the CD56+ T cells expressing
granzyme B was lower in patients compared to controls. The MFI of cells expressing granzyme
K was also significantly lower in CD8+ T cells and NK cells in patients compared to controls.
Discussion
Our study aimed to investigate the extracellular levels of granzymes A and B, as well as the
intracellular expression of granzymes A, B and K in different lymphocyte subsets in patients
with confirmed S. Typhi infection at the time of admission and discharge, and compare them
to healthy controls. To the best of our knowledge, this is the first study to describe the expres-
sion of granzymes in patients with typhoid fever. Additionally, we intended to examine the
correlation between granzymes expression and IFN-γ levels. The present study showed an
increase in extracellular levels of granzyme A and B in patients with typhoid fever compared to
controls, and lower levels of granzyme B in patients at day of discharge compared to admis-
sion. The extracellular expression of both granzymes correlated in patients with the concentra-
tion of IFN-γ, a critical cytokine for systemic control of Salmonella infection. On the other
hand, the proportion of different subsets of lymphocytes expressing intracellularly granzyme
A and granzyme B were increased in patients at acute stage.
Typhoid fever is a systemic infection in which lymphocytes play an essential role in the pro-
tective immune response [4, 19]. In contrast to other Gram-negative bacterial infections,
typhoid fever patients usually have normal to low leucocyte numbers, and low lymphocyte
counts [17]. In corroboration, patients reported in this study had a normal leucocyte count
with markedly lower lymphocyte numbers, accompanied with a decrease in the percentage of
CD4+ T cells but an increase of CD8+ T and CD56+T cells. IFN-γ is critical for the systemic
control of S. enterica infections. Although CD4+ T cells were thought to be the key producers
of IFN-γ during Salmonella infections [19,20], it is well established that T cells and NK cells
are important sources of this cytokine [4]. Human challenge studies using attenuated S. Typhi
live oral vaccines have shown that sensitized lymphocytes proliferate and produce IFN-γ in
Fig 3. Expression of granzymes A, B and K by each lymphocyte subtype in patients with typhoid fever and controls. Percentage of
lymphocyte population expressing each granzyme (A–D) and MFI of the intracellular expression of each granzyme in the lymphocyte
populations (E–H). n = 36 controls and 8 patients. MFI values are expressed with Log10 scale. Significance determined via Mann-Whitney U
tests. Medians are shown. Analysis was done by flow cytometry. MFI: median fluorescence intensity; NK cells: CD3−CD56+. *P<0.05,
**P<0.01, ***P<0.001.
https://doi.org/10.1371/journal.pntd.0005823.g003
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response to a number of S. Typhi-antigens [20]. CD4+ T cells are apparently the predominant
IFN-γ-secreting cells associated with this response, although CD8+ T cells are also present and
secrete IFN-γ [19, 21]. Unsurprisingly, we found elevated levels of IFN- γ in patients compared
to controls.
Granzymes are serine proteases promoting cytotoxic lymphocytes-mediated eradication of
intracellular pathogens via the induction of cell death [10]. Granzymes are delivered intracellu-
larly into target cells where they can activate pathways of apoptosis. Furthermore, granzymes
can be released into the extracellular environment by both immune and non-immune cells,
and may propagate cytokine processing and inflammation, so having other functions than
intracellular cytotoxicity [10]. Elevated levels of soluble granzymes have been reported in
many different infectious diseases, reaching peak levels in patients with severe sepsis [11, 13].
In addition, we have demonstrated earlier that bacterial stimuli can induce the extracellular
release of granzymes [11]. A study using PBMCs from individuals immunized with the Ty21a
typhoid vaccine, has shown that CD8+ T cell-induced cytotoxicity was mediated by the granule
exocytosis pathway [7], involving the release of perforin and granzymes into the intercellular
space, thereby mediating cell death [8, 10]. Another report, however, provided results demon-
strating that IFN-γ–independent cytotoxic mechanisms, mediated by granzymes or perforin
[6], were not sufficient for NK cell—mediated limitation of the bacterial replication of S.
Typhimurium. In the present study, we demonstrate that plasma concentrations of extracellu-
lar granzyme A and granzyme B were both elevated in typhoid fever at day of admission. Dis-
ease severity correlated with extracellular granzymes, as plasma granzyme correlated with
IFN-γ levels and lower levels were seen on day of discharge compared to admission, which is
in line with an earlier study using the typhoid vaccine [19]. This may suggest a role for gran-
zymes in the stimulation of IFN-γ release, or that the inflammatory process simultaneously
activates the release of both proteins. Of note, extracellular granzyme A, but not B, was signifi-
cantly elevated in culture-positive patients suggesting that bacteria circulating in the blood-
stream are potent inducers of extracellular granzyme A release.
When we explored the intracellular expression of granzyme A, B and K in lymphocytes by
flow cytometry, we found that, in spite of the decreased numbers of lymphocytes, both the
numbers (although non-significant) and the percentages of granzyme A and B, were increased
in culture-proven typhoid fever patients compared to controls. As expected [14], we observed
that the CD3+ lymphocytes were the main producers of the intracellular granzymes, both in
controls and patients. In this study, we also found that all subsets of lymphocytes were express-
ing granzyme A in significantly higher percentages and with greater MFI (that is, the gran-
zyme+ cells were expressing increased amounts of granzyme) in patients than in controls,
suggesting a role for granzyme A during typhoid fever. For granzyme B, the percentage of
CD8+T and CD4+T cells, but not CD56+T and NK cells, expressing the granzyme was signifi-
cantly higher in patients than in controls. It is worth noting here that the percentage of NK
and CD56+T cells expressing granzyme B was already very high in control individuals (around
90%). However, in contrast to granzyme A, the MFI of cells expressing granzyme B did not sig-
nificantly increase, and were even decreased in CD56+T cells. Regarding granzyme K, which is
thought to stimulate monocytic cells to secrete pro-inflammatory mediators like granzyme A,
our results do not indicate a role for this granzyme in these patients. Further studies are
needed to confirm these findings and see whether granzymes are indeed playing a role in the
host defense against Salmonella Typhi.
In summary, patients demonstrated a marked increase of extracellular levels of granzyme A
and B in acute phase plasma of patients with typhoid fever, and showed evidence for an associ-
ation of these granzymes with higher levels of IFN- γ and with disease severity. Lymphocytes
Granzymes in typhoid fever
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of typhoid fever patients showed higher levels of intracellular granzyme A and B, but not K,
compared to healthy controls.
Acknowledgments
We like to thank the physicians, nurses, research-assistants and technicians of Chittagong
Medical College Hospital, Chittagong, Bangladesh. Furthermore we would like to thank Steve
Baker and technicians of the Oxford University Clinical Research Unit, Hospital for Tropical
Diseases, Ho Chi Minh City, Vietnam, for performing PCRs on patients samples.
Author Contributions
Conceptualization: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Christopher M. Parry,
Tom van der Poll, Willem Joost Wiersinga.
Data curation: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Christopher M. Parry.
Formal analysis: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Christopher M. Parry.
Funding acquisition: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Christopher M. Parry,
Rapeephan R. Maude, Willem Joost Wiersinga.
Investigation: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Arie J. Hoogendijk, Christo-
pher M. Parry, Rapeephan R. Maude.
Methodology: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Christopher M. Parry, Arjen
M. Dondorp, Mohammed Abul Faiz, Tom van der Poll, Willem Joost Wiersinga.
Project administration: Hanna K. de Jong, Christopher M. Parry, Mohammed Abul Faiz,
Willem Joost Wiersinga.
Resources: Arjen M. Dondorp, Mohammed Abul Faiz, Tom van der Poll.
Supervision: Christopher M. Parry, Tom van der Poll.
Validation: Christopher M. Parry, Willem Joost Wiersinga.
Visualization: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Arie J. Hoogendijk.
Writing – original draft: Hanna K. de Jong, Willem Joost Wiersinga.
Writing – review & editing: Hanna K. de Jong, Maria Isabel Garcia-Laorden, Christopher M.
Parry, Tom van der Poll, Willem Joost Wiersinga.
References
1. Crump JA, Mintz ED. Global trends in typhoid and paratyphoid Fever. Clin Infect Dis. 2010; 50(2):241–
6. https://doi.org/10.1086/649541 PMID: 20014951
2. de Jong HK, Parry CM, van der Poll T, Wiersinga WJ. Host-pathogen interaction in invasive salmonello-
sis. PLoS Pathog. 2012; 8(10):e1002933. https://doi.org/10.1371/journal.ppat.1002933 PMID:
23055923
3. Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. Typhoid fever. Lancet. 2014:1–10. https://
doi.org/10.1016/S0140-6736(13)62708-7
4. Sztein MB, Salerno-Goncalves R, McArthur MA. Complex adaptive immunity to enteric fevers in
humans: lessons learned and the path forward. Front Immunol. 2014; 5:516. https://doi.org/10.3389/
fimmu.2014.00516 PMID: 25386175
5. Waddington CS, Darton TC, Woodward WE, Angus B, Levine MM, Pollard AJ. Advancing the manage-
ment and control of typhoid fever: a review of the historical role of human challenge studies. J Infect.
2014; 68(5):405–18. https://doi.org/10.1016/j.jinf.2014.01.006 PMID: 24491597
Granzymes in typhoid fever
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005823 July 27, 2017 11 / 12
6. Kupz A, Scott TA, Belz GT, Andrews DM, Greyer M, Lew AM, et al. Contribution of Thy1+ NK cells to
protective IFN-gamma production during Salmonella typhimurium infections. Proc Natl Acad Sci U S A.
2013; 110(6):2252–7. https://doi.org/10.1073/pnas.1222047110 PMID: 23345426
7. Salerno-Goncalves R, Fernandez-Vina M, Lewinsohn DM, Sztein MB. Identification of a human HLA-E-
restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain
Ty21a typhoid vaccine. J Immunol. 2004; 173(9):5852–62. PMID: 15494539
8. Bovenschen N, Kummer JA. Orphan granzymes find a home. Immunol Rev. 2010; 235(1):117–27.
https://doi.org/10.1111/j.0105-2896.2010.00889.x PMID: 20536559
9. Boivin WA, Cooper DM, Hiebert PR, Granville DJ. Intracellular versus extracellular granzyme B in
immunity and disease: challenging the dogma. Lab Invest. 2009; 89(11):1195–220. https://doi.org/10.
1038/labinvest.2009.91 PMID: 19770840
10. Anthony DA, Andrews DM, Watt SV, Trapani JA, Smyth MJ. Functional dissection of the granzyme fam-
ily: cell death and inflammation. Immunol Rev. 2010; 235(1):73–92. https://doi.org/10.1111/j.0105-
2896.2010.00907.x PMID: 20536556
11. Lauw FN, Simpson AJ, Hack CE, Prins JM, Wolbink AM, van Deventer SJ, et al. Soluble granzymes are
released during human endotoxemia and in patients with severe infection due to gram-negative bacte-
ria. J Infect Dis. 2000; 182(1):206–13. https://doi.org/10.1086/315642 PMID: 10882599
12. Shah D, Kiran R, Wanchu A, Bhatnagar A. Soluble granzyme B and cytotoxic T lymphocyte activity in
the pathogenesis of systemic lupus erythematosus. Cell Immunol. 2011; 269(1):16–21. https://doi.org/
10.1016/j.cellimm.2011.03.004 PMID: 21458778
13. Napoli AM, Fast LD, Gardiner F, Nevola M, Machan JT. Increased granzyme levels in cytotoxic T lym-
phocytes are associated with disease severity in emergency department patients with severe sepsis.
Shock. 2012; 37(3):257–62. https://doi.org/10.1097/SHK.0b013e31823fca44 PMID: 22089193
14. Garcia-Laorden MI, Blok DC, Kager LM, Hoogendijk AJ, van Mierlo GJ, Lede IO, et al. Increased intra-
and extracellular granzyme expression in patients with tuberculosis. Tuberculosis (Edinb). 2015; 95
(5):575–80. https://doi.org/10.1016/j.tube.2015.05.016 PMID: 26156785
15. Maude RR, de Jong HK, Wijedoru L, Fukushima M, Ghose A, Samad R, et al. The diagnostic accuracy
of three rapid diagnostic tests for typhoid fever at Chittagong Medical College Hospital, Chittagong,
Bangladesh. Trop Med Int Health. 2015; 20(10):1376–84. https://doi.org/10.1111/tmi.12559 PMID:
26094960
16. De Jong HK, Achouiti A, Koh GC, Parry CM, Baker S, Faiz MA, et al. Expression and function of
S100A8/A9 (calprotectin) in human typhoid fever and the murine Salmonella model. PLoS Negl Trop
Dis. 2015; 9(4):e0003663. https://doi.org/10.1371/journal.pntd.0003663 PMID: 25860480
17. Tsolis RM, Young GM, Solnick JV, Baumler AJ. From bench to bedside: stealth of enteroinvasive patho-
gens. Nat Rev Microbiol. 2008; 6(12):883–92. https://doi.org/10.1038/nrmicro2012 PMID: 18955984
18. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what’s in a name? Nat
Rev Immunol. 2004; 4(3):231–7. https://doi.org/10.1038/nri1309 PMID: 15039760
19. Lundgren A, Kaim J, Jertborn M. Parallel analysis of mucosally derived B- and T-cell responses to an
oral typhoid vaccine using simplified methods. Vaccine. 2009; 27(33):4529–36. https://doi.org/10.1016/
j.vaccine.2009.05.005 PMID: 19446596
20. Sztein MB, Wasserman SS, Tacket CO, Edelman R, Hone D, Lindberg AA, et al. Cytokine production
patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine
strains of Salmonella typhi. J Infect Dis. 1994; 170(6):1508–17. PMID: 7995991
21. Dougan G, John V, Palmer S, Mastroeni P. Immunity to salmonellosis. Immunol Rev. 2011; 240
(1):196–210. Epub 2011/02/26. doi: 10.1111/j.1600-065X.2010.00999.x. PMID: 21349095
Granzymes in typhoid fever
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005823 July 27, 2017 12 / 12
